Your browser doesn't support javascript.
loading
Correlation of Smad4 status with outcomes in patients receiving erlotinib combined with adjuvant chemoradiation and chemotherapy after resection for pancreatic adenocarcinoma.
Herman, Joseph M; Fan, Katherine Y; Wild, Aaron T; Wood, Laura D; Blackford, Amanda L; Donehower, Ross C; Hidalgo, Manuel; Schulick, Richard D; Edil, Barish H; Choti, Michael A; Hruban, Ralph H; Pawlik, Timothy M; Cameron, John L; Laheru, Daniel A; Iacobuzio-Donahue, Christine A; Wolfgang, Christopher L.
Afiliação
  • Herman JM; Department of Radiation Oncology & Molecular Radiation Sciences, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: jherma15@jhmi.edu.
Int J Radiat Oncol Biol Phys ; 87(3): 458-9, 2013 Nov 01.
Article em En | MEDLINE | ID: mdl-24074918

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Proteína Smad4 Idioma: En Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Proteína Smad4 Idioma: En Ano de publicação: 2013 Tipo de documento: Article